Ingrid Wertz
Company: Lyterian Therapeutics
Job title: CEO
Seminars:
Leveraging the Progression of Molecular Glues in the Clinic to Better Inform the Translation of Novel Glue Candidates 3:30 pm
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Day One